ArticleGastroenterology2012
Which Therapy for Helicobacter pylori Infection?
Article in Gastroenterology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Effect of fluoroquinolone resistance on 14-day levofloxacin triple and triple plus bismuth quadruple therapy.Helicobacter · 2013Trial
- Impact of previous metronidazole exposure on metronidazole-based second-line quadruple therapy for Helicobacter pylori infection.The Korean journal of internal medicine · 2020Article
- Helicobacter pylori: A Review of Current Diagnostic and Management Strategies.Digestive diseases and sciences · 2020Review
- Effectiveness of 7-Day and 14-Day Moxifloxacin-Dexlansoprazole Based Triple Therapy and Probiotic Supplement for Helicobacter Pylori Eradication in Thai Patients with Non-Ulcer Dyspepsia: A Double-Blind Randomized Placebo-Controlled StudyAsian Pacific journal of cancer prevention : APJCP · 2017Article
- First-line therapies forAnnals of gastroenterology · 2017Review
- Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA.Digestive diseases and sciences · 2016Article
- Eradication of Helicobacter pylori Infection.Current gastroenterology reports · 2016Review
- Review article: the global emergence of Helicobacter pylori antibiotic resistance.Alimentary pharmacology & therapeutics · 2016Review
- Antibiotic treatment for Helicobacter pylori: Is the end coming?World journal of gastrointestinal pharmacology and therapeutics · 2015Review
- Review
- Pyridodiazepine amines are selective therapeutic agents for helicobacter pylori by suppressing growth through inhibition of glutamate racemase but are predicted to require continuous elevated levels in plasma to achieve clinical efficacy.Antimicrobial agents and chemotherapy · 2015Article
- Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2014Article
- Eradication of Helicobacter pylori infection: which regimen first?World journal of gastroenterology · 2014Review
- Helicobacter pylori: future perspectives in therapy reflecting three decades of experience.World journal of gastroenterology · 2014Review
- Therapy of Helicobacter pylori: present medley and future prospective.BioMed research international · 2014Review
- Real-Time PCR detection and quantitation ofAnnals of gastroenterology · 2013Article
Corrections and comments
- Commented on by
- Comment on
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.